Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Non Operating Income (2023 - 2025)

Rallybio (RLYB) has disclosed Non Operating Income for 3 consecutive years, with $22.9 million as the latest value for Q3 2025.

  • Quarterly Non Operating Income rose 1754.57% to $22.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $23.2 million through Dec 2025, up 5922.81% year-over-year, with the annual reading at $22.8 million for FY2025, 2960.62% up from the prior year.
  • Non Operating Income hit $22.9 million in Q3 2025 for Rallybio, up from $118000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $22.9 million in Q3 2025 to a low of -$3.2 million in Q4 2024.
  • Historically, Non Operating Income has averaged $2.2 million across 3 years, with a median of $143000.0 in 2024.
  • Biggest YoY gain for Non Operating Income was 1876.71% in 2024; the steepest drop was 9305.71% in 2024.
  • Year by year, Non Operating Income stood at $35000.0 in 2023, then plummeted by 9305.71% to -$3.2 million in 2024, then surged by 812.01% to $22.9 million in 2025.
  • Business Quant data shows Non Operating Income for RLYB at $22.9 million in Q3 2025, $118000.0 in Q2 2025, and $174000.0 in Q1 2025.